eMedicine Specialties > Dermatology > Pediatric Diseases

Naegeli-Franceschetti-Jadassohn Syndrome

Author: Theo Rufli, MD, Professor of Dermatology and Venereology, Chair, Department of Dermatology, University Hospital of Basle, Switzerland
Contributor Information and Disclosures

Updated: Dec 2, 2009

Introduction

Background

Description

Naegeli-Franceschetti-Jadassohn (NFJ) syndrome is a rare autosomal dominant form of ectodermal dysplasia that affects the skin, sweat glands, nails, and teeth. The incidence is estimated to be 1 case in 2-4 million population. NFJ syndrome is entry 161000 in the Online Mendelian Inheritance in Man database. The syndrome is allelic to dermatopathia pigmentosa reticularis.

In 1927, Naegeli first described the syndrome as familiãrer Chromatophoren-Naevus in a Swiss family. In 1954, Franceschetti and Jadassohn further analyzed the syndrome, as did Itin and colleagues in 1993.

NFJ syndrome is a reticulate pigmentary disorder. Other reticulate pigmentary diseases include X-linked reticulate pigmentary disorder, dermatopathia pigmentosa reticularis, Dowling-Degos disease, dyschromatosis, confluent and reticulated papillomatosis of Gougerot and Carteaud, and reticulated acropigmentation of Kitamura.

Differential diagnoses

Franceschetti and Jadassohn distinguished Naegeli syndrome from incontinentia pigmenti (Bloch-Sulzberger syndrome) by the equal frequency of the disorder in males and females and by the presence of palmar and plantar hyperkeratosis, hypohidrosis, and dental abnormalities. In contrast, incontinentia pigmenti is inherited as an X-linked dominant trait.

Hereditary bullous acrokeratotic poikiloderma of Weary-Kindler has some striking similarities to NFJ syndrome. However, hyperhidrosis is not reported with this entity, and dental abnormalities are only rarely observed.1

Changes in the rete ridges such as those in Dowling-Degos disease and amyloid deposition such as that in macular amyloidosis are not found in NFJ syndrome.2,3 Changes in hair follicles or apocrine ducts do not occur in NFJ syndrome; this observation excludes Fox-Fordyce disease.4

Pathophysiology

Naegeli-Franceschetti-Jadassohn (NFJ) syndrome may be associated with a number of markers located in the vicinity of the type I keratin gene cluster on band 17q21 (see Causes).

Frequency

United States

Naegeli-Franceschetti-Jadassohn (NFJ) syndrome is rare.

International

The estimated incidence of Naegeli-Franceschetti-Jadassohn (NFJ) syndrome is approximately 1 case in 2-4 million population.

Race

Several families with Naegeli-Franceschetti-Jadassohn (NFJ) syndrome have been reported in Switzerland, Japan, Italy, and Greece (see Physical).

Sex

No sexual predilection is recognized for Naegeli-Franceschetti-Jadassohn (NFJ) syndrome.

Age

Because of the inability to sweat, Naegeli-Franceschetti-Jadassohn (NFJ) syndrome is usually diagnosed early in life. The lack of fingerprint lines (ie, dermatoglyphics) can be easily checked.

Clinical

History

  • Compared with reticulate hyperpigmentation, which fades, hypohidrosis and palmoplantar keratoderma usually persist in Naegeli-Franceschetti-Jadassohn (NFJ) syndrome.
  • In a recent reexamination of the original family, the natural history of the syndrome was described. The pedigree now documents findings in 6 generations including 62 members with 14 persons affected by NFJ syndrome.
  • Further data has been accumulated from the original family with NFJ syndrome.
    • Mevorah et al examined 2 patients and documented a mild reduction in the number of functional sweat glands when they were exposed to moderate heat stress.5 However, the patients remained comfortable and had normal thermal regulation.
    • In addition, Frenk et al performed an electron microscopic study of skin samples from 2 members in the original family.6 Pigment incontinence was accompanied by varying amounts of colloid-amyloid bodies in the papillar dermis and occasionally around sweat glands in the reticular dermis. This finding is also described in incontinentia pigmenti.7

Physical

  • The main syndrome of Naegeli-Franceschetti-Jadassohn (NFJ) syndrome, an ectodermal dysplasia, is heat intolerance worsened by reduced sweating, with a potential to cause collapse, flushing, and dizziness after even mild exercise.
  • Clinically, patients lack dermatoglyphics, or fingerprint lines, as shown below.

    • Lack of dermatoglyphics in a patient with Naegeli...

      Lack of dermatoglyphics in a patient with Naegeli-Franceschetti-Jadassohn syndrome.

      Lack of dermatoglyphics in a patient with Naegeli...

      Lack of dermatoglyphics in a patient with Naegeli-Franceschetti-Jadassohn syndrome.

  • Patients also have a characteristic reticular pigmentation on their neck, chest, and abdomen, shown below, that begins when they are aged 1-5 years and improves after puberty.

    • Reticulated pigmentation on the trunk in a patien...

      Reticulated pigmentation on the trunk in a patient with Naegeli-Franceschetti-Jadassohn syndrome.

      Reticulated pigmentation on the trunk in a patien...

      Reticulated pigmentation on the trunk in a patient with Naegeli-Franceschetti-Jadassohn syndrome.

    • In many cases, the pigmentation completely resolves at adolescence.
    • In addition, increased spotlike pigmentation may be present around the mouth and eyes, as in the image below.

    • Periorbital reticulated pigmentation in a patient...

      Periorbital reticulated pigmentation in a patient with Naegeli-Franceschetti-Jadassohn syndrome.

      Periorbital reticulated pigmentation in a patient...

      Periorbital reticulated pigmentation in a patient with Naegeli-Franceschetti-Jadassohn syndrome.

  • Affected individuals have mild palmoplantar keratosis, depicted below, brittle fingernails, and defective dentures with yellow spots on the enamel, shown below.8,9,10

    • Spotty palmoplantar hyperkeratosis in Naegeli-Fra...

      Spotty palmoplantar hyperkeratosis in Naegeli-Franceschetti-Jadassohn syndrome.

      Spotty palmoplantar hyperkeratosis in Naegeli-Fra...

      Spotty palmoplantar hyperkeratosis in Naegeli-Franceschetti-Jadassohn syndrome.


    • Defective denture with yellow spots on the enamel...

      Defective denture with yellow spots on the enamel in a patient with Naegeli-Franceschetti-Jadassohn syndrome.

      Defective denture with yellow spots on the enamel...

      Defective denture with yellow spots on the enamel in a patient with Naegeli-Franceschetti-Jadassohn syndrome.

  • To date, all patients reported had normal intelligence and were usually in good health.
  • Incomplete forms of variations of NFJ syndrome are reported.10,11
    • Several slightly different clinical phenotypes and intrafamilial variability are also reported.12,13,14
    • Malalignment of the great toenails14 and periungual and mucosal pigmentation are only rarely observed. Characteristically, the pigmentation starts without a preceding inflammatory stage.
  • Besides the families in Switzerland, Japan, and Italy,13 an additional patient was identified in Greece.15,16
    • In this patient's family, the reticular hyperpigmentation was accentuated on the flexural areas of the arms and legs; neck; axillae; and cruroinguinal, antecubital, and popliteal regions, where extensive milia formation was observed.
    • The formation of milia had not been reported in the other patients.
    • In the father and grandfather of this patient, the generalized reticular hyperpigmentation was reported to have faded in adulthood. The hyperpigmented macules varied in color (brown to black), pattern, and distribution. Some of the macules were frecklelike or angulated, and they tended to form a reticulate pattern. Others had a mottled pattern or formed streaks and whorls.

Causes

In the single family of British origin, 25 members are affected by Naegeli-Franceschetti-Jadassohn (NFJ) syndrome, and 37 are unaffected.10 Markers located on chromosome arms 1q, 12q, 18q were excluded for links to the disease; this finding indicated that the gene for NFJ syndrome was not located in the epidermal differentiation complex, the type II keratin cluster, or the desmosomal cadherin cluster, respectively.

In contrast, a highly significant linkage was detected with a number of markers located in the vicinity of the type I keratin gene cluster on band 17q21. With maximum 2-lod scores of 4.16 and 3.717 for the markers D17S1787 and D17S1886, respectively.17 Hence, the genetic defect in this family is located between the microsatellite markers D17S798 and D17S957, which are separated by approximately 26.97 cM. However, the gene defect is still unknown. Other genes that encode differentiation-specific keratins such as the type I keratins K-15, K-19, and K-20; plakoglobin; and the MEOX1 gene have been excluded.17

The lack of dermatoglyphics is likely due to a defective protein that is involved in epithelial development and/or epithelial-mesenchymal interactions perhaps less likely due to the structure of the molecule. A number of candidate genes of this type have been mapped to the region critical to NFJ syndrome; these include the granulin gene that encodes a protein involved in epithelium growth and differentiation18 ; frizzled homolog 2, a molecule involved in epithelial cell-signaling pathways19 ; ADAM-11, a protein implicated in cell-cell and cell-matrix interactions,20 and GRB-7, a membrane-bound growth factor receptor of uncertain function21 ; and the MEOX1 gene.22

Studies suggest that NFJ syndrome is caused by mutations in KRT14, with haploinsufficiency resulting in keratinocytes being susceptible to apoptosis induced by tumor necrosis-factor-alpha.16,23,24,25

More on Naegeli-Franceschetti-Jadassohn Syndrome

Overview: Naegeli-Franceschetti-Jadassohn Syndrome
Differential Diagnoses & Workup: Naegeli-Franceschetti-Jadassohn Syndrome
Treatment & Medication: Naegeli-Franceschetti-Jadassohn Syndrome
Multimedia: Naegeli-Franceschetti-Jadassohn Syndrome
References

References

  1. Larregue M, Prigent F, Lorette G, Canuel C, Ramdenee P. [Bullous and hereditary Weary-Kindler's acrokeratotic poikiloderma (author's transl)]. Ann Dermatol Venereol. 1981;108(1):69-76. [Medline].

  2. Rebora A, Crovato F. The spectrum of Dowling-Degos disease. Br J Dermatol. May 1984;110(5):627-30. [Medline].

  3. Tidman MJ, Wells RS, MacDonald DM. Pachyonychia congenita with cutaneous amyloidosis and hyperpigmentation--a distinct variant. J Am Acad Dermatol. May 1987;16(5 Pt 1):935-40. [Medline].

  4. Arnold H, Odon R, James W. Andrews Diseases of the Skin: Clinical Dermatology. 9th ed. Harcourt Brace and Co; 2000:684.

  5. Mevorah B, Frascarolo P, Gianadda E, Donatsch J. Sweat studies under conditions of moderate heat stress in two patients with the Nägeli-Franceschetti-Jadassohn syndrome. Dermatology. 1993;187(3):174-7. [Medline].

  6. Frenk E, Mevorah B, Hohl D. The Nägeli-Franceschetti-Jadassohn syndrome: A hereditary ectodermal defect leading to colloid-amyloid formation in the dermis. Dermatology. 1993;187(3):169-73. [Medline].

  7. Zillikens D, Mehringer A, Lechner W, Burg G. Hypo- and hyperpigmented areas in incontinentia pigmenti. Light and electron microscopic studies. Am J Dermatopathol. Feb 1991;13(1):57-62. [Medline].

  8. Naegeli O. Familiarer Chromnatophotennes. Schweiz Med Wochenschr. 1927;8:48.

  9. Franceschetti A, Jadassohn W. [On incontinentia pigmenti and differentiation of two syndromes appearing under the same name.]. Dermatologica. Jan 1954;108(1):1-28. [Medline].

  10. Sparrow GP, Samman PD, Wells RS. Hyperpigmentation and hypohidrosis. (The Naegeli-Franceschetti-Jadassohn syndrome): report of a family and review of the literature. Clin Exp Dermatol. Jun 1976;1(2):127-40. [Medline].

  11. Kitamura K, Hirako T. [Two Japanese cases of a peculiar reticulous pigmentation.]. Dermatologica. Feb 1955;110(2):97-107. [Medline].

  12. Levi L, Galbiati G, Ghislanzoni G. [Reticular pigmentary dermatitis of Franceschetti-Jadassohn syndrome. Case report]. G Ital Dermatol Minerva Dermatol. Jul 1971;46(7):319-22. [Medline].

  13. Papini M. Sindrome di Naegeli-Franceschetti-Jadassohn. Ann Ital Dermatol Clin Sper. 1978;32:281-292.

  14. Itin PH, Lautenschlager S, Meyer R, Mevorah B, Rufli T. Natural history of the Naegeli-Franceschetti-Jadassohn syndrome and further delineation of its clinical manifestations. J Am Acad Dermatol. Jun 1993;28(6):942-50. [Medline].

  15. Tzermias C, Zioga A, Hatzis I. Reticular pigmented genodermatosis with milia--a special form of Naegeli-Franceschetti-Jadassohn syndrome or a new entity?. Clin Exp Dermatol. Jul 1995;20(4):331-5. [Medline].

  16. Whiting DA. Naegeli´s reticular pigmented dermatosis. Br J Dermatol. 1971;85:71-73.

  17. Whittock NV, Coleman CM, McLean WH, et al. The gene for Naegeli-Franceschetti-Jadassohn syndrome maps to 17q21. J Invest Dermatol. Oct 2000;115(4):694-8. [Medline].

  18. Bhandari V, Bateman A. Structure and chromosomal location of the human granulin gene. Biochem Biophys Res Commun. Oct 15 1992;188(1):57-63. [Medline].

  19. Zhao Z, Lee CC, Baldini A, Caskey CT. A human homologue of the Drosophila polarity gene frizzled has been identified and mapped to 17q21.1. Genomics. May 20 1995;27(2):370-3. [Medline].

  20. Emi M, Katagiri T, Harada Y, et al. A novel metalloprotease/disintegrin-like gene at 17q21.3 is somatically rearranged in two primary breast cancers. Nat Genet. Oct 1993;5(2):151-7. [Medline].

  21. Margolis B, Silvennoinen O, Comoglio F, et al. High-efficiency expression/cloning of epidermal growth factor-receptor-binding proteins with Src homology 2 domains. Proc Natl Acad Sci U S A. Oct 1 1992;89(19):8894-8. [Medline].

  22. Froelich S, Houlden H, Rizzu P, et al. Construction of a detailed physical and transcript map of the FTDP-17 candidate region on chromosome 17q21. Genomics. Sep 1 1999;60(2):129-36. [Medline].

  23. Lugassy J, Itin P, Ishida-Yamamoto A, et al. Naegeli-Franceschetti-Jadassohn syndrome and dermatopathia pigmentosa reticularis: two allelic ectodermal dysplasias caused by dominant mutations in KRT14. Am J Hum Genet. Oct 2006;79(4):724-30. [Medline].

  24. Lugassy J, McGrath JA, Itin P, et al. KRT14 haploinsufficiency results in increased susceptibility of keratinocytes to TNF-alpha-induced apoptosis and causes Naegeli-Franceschetti-Jadassohn syndrome. J Invest Dermatol. Jun 2008;128(6):1517-24. [Medline].

  25. Dereure O. [Naegeli-Franceschetti-Jadassohn syndrome and dermatopathia pigmentosa reticularis. Two allelic ectodermal dysplasias related to mutations of dominant gene coding for keratin 14]. Ann Dermatol Venereol. Jun-Jul 2007;134(6-7):595. [Medline].

  26. Engman MF. Congenital atrophy of the skin with reticular pigmentation. JAMA. 1935;103:1252-6.

  27. Fulk CS. Primary disorders of hyperpigmentation. J Am Acad Dermatol. Jan 1984;10(1):1-16. [Medline].

  28. Griffiths WA. Reticulate pigmentary disorders--a review. Clin Exp Dermatol. Sep 1984;9(5):439-50. [Medline].

  29. Heimer WL 2nd, Brauner G, James WD. Dermatopathia pigmentosa reticularis: a report of a family demonstrating autosomal dominant inheritance. J Am Acad Dermatol. Feb 1992;26(2 Pt 2):298-301. [Medline].

  30. Kudo Y, Fujiwara S, Takayasu S, Ooki H, Ogawa A. Reticulate pigmentary dermatosis associated with hypohydrosis and short stature: a variant of Naegeli-Franceschetti-Jadassohn syndrome?. Int J Dermatol. Jan 1995;34(1):30-1. [Medline].

  31. Maso MJ, Schwartz RA, Lambert WC. Dermatopathia pigmentosa reticularis. Arch Dermatol. Jul 1990;126(7):935-9. [Medline].

  32. Schnur RE, Heymann WR. Reticulate hyperpigmentation. Semin Cutan Med Surg. Mar 1997;16(1):72-80. [Medline].

  33. Zinsser F. Atrophia curis reticularis cum pigmentatione, dystrophia et leukoplakia oris. Ikonogr Dermat. 1910;5:219-223.

Further Reading

Keywords

Naegeli-Franceschetti-Jadassohn syndrome, NFJ syndrome, MIM 161000, reticulate pigmentary disorders, ectodermal dysplasia, hyperpigmentation, hypohidrosis, palmoplantar keratoderma

Contributor Information and Disclosures

Author

Theo Rufli, MD, Professor of Dermatology and Venereology, Chair, Department of Dermatology, University Hospital of Basle, Switzerland
Disclosure: Nothing to disclose.

Medical Editor

James Fulton Jr, MD, PhD, Center for Cosmetic Dermatology; Consultant, Vivant Pharmaceuticals, LLC
James Fulton Jr, MD, PhD is a member of the following medical societies: American Academy of Cosmetic Surgery, American Academy of Dermatology, American Society for Laser Medicine and Surgery, Dermatology Foundation, International Society of Cosmetic and Laser Surgeons, and Skin Cancer Foundation
Disclosure: vivant pharmaceuticals Ownership interest Consulting

Pharmacy Editor

David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Managing Editor

Robert A Schwartz, MD, MPH, Professor and Head, Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School
Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi
Disclosure: Nothing to disclose.

CME Editor

Glen H Crawford, MD, Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital
Glen H Crawford, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, Phi Beta Kappa, and Society of USAF Flight Surgeons
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.